Efficacy of levosimendan infusion in patients undergoing a left ventricular assist device implant in a propensity score matched analysis of the EUROMACS registry-the Euro LEVO-LVAD study. [PDF]
Eur J Cardiothorac Surg, 2023 Abdelshafy M +17 more
europepmc +1 more source
Prediction of long-term survival and coagulation factor VIII levels: interactions with gender in a large hospital-based cohort [PDF]
, 2014 Endler, G +6 more
core +1 more source
Levosimendan: efficacy and safety in pediatric heart failure treatment. [PDF]
Rev Assoc Med Bras (1992)Dündar MA, Yılmaz M, Argun M.
europepmc +1 more source
Levosimendan for VA-ECMO weaning: the silver lining. [PDF]
ESC Heart Fail, 2022 Kaddoura R, Mohamed Ibrahim MI, Omar A.
europepmc +1 more source
Population Pharmacokinetics of Levosimendan and its Metabolites OR-1855 and OR-1896 in Critically Ill Adults, Neonates and Infants on Veno-Arterial ECMO. [PDF]
Clin PharmacokinetBertin S +11 more
europepmc +1 more source
Evaluation of levosimendan as treatment option in a large case-series of preterm infants with cardiac dysfunction and pulmonary hypertension. [PDF]
Eur J Pediatr, 2023 Schroeder L +7 more
europepmc +1 more source
Levosimendan comes of age: twenty years in clinical use [PDF]
, 2020 Alvarez, J. +9 more
core +2 more sources
Levosimendan Pretreatment Attenuates Mesenteric Artery Ischemia/Reperfusion Injury and Multi-Organ Damage in Rats. [PDF]
Int J Mol SciMatković Z +12 more
europepmc +1 more source
Levosimendan for postoperative subclinical heart failure after noncardiac surgery: a randomized, double-blinded, phase III trial. [PDF]
Nat CommunReiterer C +12 more
europepmc +1 more source
Levosimendan improves the acute course of takotsubo syndrome: a pooled analysis. [PDF]
ESC Heart Fail, 2021 Jaguszewski MJ +6 more
europepmc +1 more source